Research Groups and R&D Platforms: In Vitro Diagnostics
Research Group:
Bacterial infections: translational genomics, immunity and prevention
Qiushui He
Qiushui.He[at]utu.fi
Institute of Biomedicine,
University of Turku
Allergy, Antibodies, Assay development, Bacteriology, Biomedicine, Epidemiology, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Infection, Inflammation, Molecular diagnostics, Nucleic acids
Research Group:
New tools to target harmful inflammations and cancer
Sirpa Jalkanen
sirjal[at]utu.fi
Institute of Biomedicine,
University of Turku
Cell Trafficking in Cancer and Inflammation
Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery
Research Group:
Digital DNA diagnostics for detection of antimicrobial resistant pathogens
Ari Lehmusvuori
artule[at]utu.fi
Department of Life Technologies,
University of Turku
Antibioottiresistenttien bakteerien nopea detektio digitaalisella DNA-sensoritekniikalla
Assay development, Biochemistry, Biotechnology, Cardiovascular diseases, Clinical Chemistry, Clinical Medicine, Genetics, Genomics, In Vitro Diagnostics, Infection, Molecular diagnostics, Molecular modelling, Nucleic acids
Research Group:
The in vitro/in vivo applications of hot electrons in clinical research and health care
Heikki Peuravuori
heipeu[at]utu.fi
Institute of Biomedicine,
University of Turku
Antibacterial, Antibodies, Assay development, Bacteriology, Biochemistry, Biomarker, Biomedicine, Biotechnology, Chemical Physics, Clinical Chemistry, Electron microscopy, Fluorescence spectroscopy, Imaging software, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Medicinal chemistry, Point of care
Research Group:
Alpha2-Adrenoceptors as targets for drug development
Mika Scheinin
mschein[at]utu.fi
University of Turku, Turku University Hospital and CRST Oy
Clinical Research Services Turku
Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Genetic predisposition to cancer
Johanna Schleutker
Johanna.Schleutker[at]utu.fi
Institute of Biomedicine,
University of Turku
Antibodies, Assay development, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Breast cancer, Cancer, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, In Vitro Diagnostics, Inherited diseases, Machine learning, Molecular Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Point of care, Prostate cancer, Screening
